CGM for Non-Diabetics 2026: Lingo, Stelo & Dexcom G8 Reviewed
By Dr. Sarah Mitchell, Respiratory Equipment Specialist · Published 2026-06-05 · 7 min read
Over-the-counter CGMs are mainstream. Compare Abbott Lingo, Dexcom Stelo, and the new G8 for metabolic optimization and weight loss.
CGMs Go Mainstream
Since the FDA cleared OTC continuous glucose monitors in 2024, adoption has exploded. By 2026 the U.S. CGM-for-wellness market hit $3.2B.
Top 2026 Devices
| Device | Wear Time | Price | Best For |
|---|---|---|---|
| Abbott Lingo | 14 days | $49 | First-timers |
| Dexcom Stelo | 15 days | $89 | Accuracy seekers |
| Dexcom G8 OTC | 15 days | $129 | Athletes |
| Sibio GS | 14 days | $69 | Ketone+glucose |
Use Cases
- Spot glucose spikes from oats, white rice, juice
- Personalize meal timing around workouts
- Pair with GLP-1 therapy to verify response
- Validate time-restricted eating windows
Pro Tips
- Wear for 2 cycles (28 days) before drawing conclusions
- Always pair with food + activity logging
- Recalibrate via fingerstick if values feel off
CGMs are not a substitute for medical care. If your average glucose runs >120 mg/dL, see your doctor for an HbA1c.